MyFinsight
Home
About
Contact
elvn: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, ELVN has $490,875K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
490,875
503,887
Total stockholders' equity
476,122
488,472
Total liabilities and stockholders' equity
490,875
503,887
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Property and equipment,
gross
$1,535K
Prepaid expenses and
other current assets
$5,118K
Marketable securities
$375,833K
Cash and cash
equivalents
$101,732K
Other long-term
assets
$7,101K
Deferred offering costs
$217K
Operating lease
right-of-use assets
$475K
Property and equipment,
net
$399K
Total current assets
$482,683K
Less accumulated
depreciation
$1,136K
Total assets
$490,875K
Total liabilities and
stockholders' equity
$490,875K
Total stockholders'
equity
$476,122K
Total liabilities
$14,753K
Accumulated deficit
-$317,499K
Accumulated other
comprehensive income
$221K
Additional paid-in capital
$793,341K
Long-term liabilities
$103K
Total current
liabilities
$14,650K
Common stock, par value
0.001 authorized...
$59K
Accrued expenses and
other current...
$13,221K
Accounts payable
$1,429K
Buy me a coffee
Enliven Therapeutics, Inc. (ELVN)
Enliven Therapeutics, Inc. (ELVN)